Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections

Antimicrobial resistance (AMR) has been defined by World Health Organization as one of the top 10 global public health threats facing humanity

Without effective antimicrobials, the success of modern medicine in treating infections, including during major surgery and cancer chemotherapy, would be at increased risk. Especially alarming is the rapid global spread of multi- and pan- resistant bacteria (also known as “superbugs”) that cause infections that are no treatable with existing antimicrobial medicines such as antibiotics.